Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
R. Lee Mosley(University of Nebraska Medical Center), Howard E. Gendelman(Nebraska Medical Center), Khader M. Hasan(The University of Texas Health Science Center at Houston), Mark Thomas(University of Nebraska Medical Center), Eric J. Benner(Duke University), Irena Kadiu(UCB Pharma (Belgium)), Michael D. Boska(Nebraska Medical Center), C Doering Laurie(University of Nebraska Medical Center)
Cited by 390
Related Papers
Diagnostics for SARS-CoV-2 infections
|Nature Materials|2021|838
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson’s Disease
|The Journal of Immunology|2010|412
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
|PLoS ONE|2008|363
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
|Proceedings of the National Academy of Sciences|2004|319
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
|Nature Communications|2019|296